Y. Vandenplas

Vrije Universiteit Brussel

Health Outcomes Studied

• Improved Bowel Movement Frequency
• Reduced Colitis-Related Mortality
• Reduced Vomiting Frequency

Papers (7)

• 2023
  Limosilactobacillus reuteri DSM 17938-Containing Infant Formulas and the Associations with Gastrointestinal Tolerance: A Cross-Sectional Observational Study10.3390/nu15030530
• 2020
  Lactobacillus reuteri DSM 17938 and Magnesium Oxide in Children with Functional Chronic Constipation: A Double-Blind and Randomized Clinical Trial10.3390/nu12010225
• 2019
  Lactobacillus reuteri DSM 17938 Improves Feeding Intolerance in Preterm Infants10.5223/pghn.2019.22.6.545
• 2016
  A double-blinded randomized trial on growth and feeding tolerance with Saccharomyces boulardii CNCM I-745 in formula-fed preterm infants.10.1016/j.jped.2015.08.013
• 2015
  Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting.10.1016/j.jped.2014.10.009
• 2010
  Clinical efficacy comparison of Saccharomyces boulardii and yogurt fluid in acute non-bloody diarrhea in children: a randomized, controlled, open label study.10.4269/ajtmh.2010.09-0529
• 2007
  Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo‐controlled study10.1111/j.1651-2227.2007.00191.x